Our previous studies verified that B-Myb is upregulated in non-small-cell lung cancer (NSCLC), and a gain-of-function study has verified that overexpression of B-Myb significantly promotes lung cancer cell growth, migration, and invasion [20]. This evidence concerns the gene MYBL2 and non-small cell lung carcinoma.